Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jun;91(6):2653–2664. doi: 10.1172/JCI116504

Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.

J Van de Water 1, J Turchany 1, P S Leung 1, J Lake 1, S Munoz 1, C D Surh 1, R Coppel 1, A Ansari 1, Y Nakanuma 1, M E Gershwin 1
PMCID: PMC443329  PMID: 8514873

Abstract

Sera from patients with primary biliary cirrhosis (PBC) react with enzymes of the 2-oxo dehydrogenase pathways, particularly PDC-E2. These enzymes are present in all nucleated cells, yet autoimmune damage is confined to biliary epithelial cells. Using a panel of eight mouse monoclonal antibodies and a human combinatorial antibody specific for PDC-E2, we examined by indirect immunofluorescence and confocal microscopy sections of liver from patients with PBC, progressive sclerosing cholangitis, and hepatocarcinoma. The monoclonal antibodies gave typical mitochondrial immunofluorescence on biliary epithelium and on hepatocytes from patients with either PBC, progressive sclerosing cholangitis, or hepatocarcinoma. However, one of eight mouse monoclonal antibodies (C355.1) and the human combinatorial antibody reacted with great intensity and specificity with the luminal region of biliary epithelial cells from patients with PBC. Simultaneous examination of these sections with an antiisotype reagent for human IgA revealed high IgA staining in the luminal region of biliary epithelial cells in patients with PBC. IgG and IgA antibodies to PDC-E2 were detected in the bile of patients with PBC but not normal controls. We believe that this data may be interpreted as indicating that a molecule cross-reactive with PDC-E2 is expressed at high levels in the luminal region of biliary epithelial cells in PBC.

Full text

PDF
2656

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown W. R., Kloppel T. M. The role of the liver in translocation of IgA into the gastrointestinal tract. Immunol Invest. 1989 Jan-May;18(1-4):269–285. doi: 10.3109/08820138909112242. [DOI] [PubMed] [Google Scholar]
  2. Cha S., Leung P. S., Gershwin M. E., Fletcher M. P., Ansari A. A., Coppel R. L. Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2527–2531. doi: 10.1073/pnas.90.6.2527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Culp K. S., Fleming C. R., Duffy J., Baldus W. P., Dickson E. R. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc. 1982 Jun;57(6):365–370. [PubMed] [Google Scholar]
  4. Delacroix D. L., Malburny G. N., Vaerman J. P. Hepatobiliary transport of plasma IgA in the mouse: contribution to clearance of intravascular IgA. Eur J Immunol. 1985 Sep;15(9):893–899. doi: 10.1002/eji.1830150906. [DOI] [PubMed] [Google Scholar]
  5. Domar U., Danielsson A., Hirano K., Stigbrand T. Alkaline phosphatase isozymes in non-malignant intestinal and hepatic diseases. Scand J Gastroenterol. 1988 Sep;23(7):793–800. doi: 10.3109/00365528809090762. [DOI] [PubMed] [Google Scholar]
  6. Fregeau D. R., Roche T. E., Davis P. A., Coppel R., Gershwin M. E. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme. J Immunol. 1990 Mar 1;144(5):1671–1676. [PubMed] [Google Scholar]
  7. Fussey S. P., Guest J. R., James O. F., Bassendine M. F., Yeaman S. J. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8654–8658. doi: 10.1073/pnas.85.22.8654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gershwin M. E., Coppel R. L., Mackay I. R. Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology. Hepatology. 1988 Jan-Feb;8(1):147–151. doi: 10.1002/hep.1840080128. [DOI] [PubMed] [Google Scholar]
  9. Hansen B. U., Lindgren S., Eriksson S., Henricsson V., Larsson A., Manthorpe R., Warfvinge G. Clinical and immunological features of Sjögren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand. 1988;224(6):611–619. doi: 10.1111/j.0954-6820.1988.tb19634.x. [DOI] [PubMed] [Google Scholar]
  10. Hershko A. The ubiquitin pathway of protein degradation and proteolysis of ubiquitin-protein conjugates. Biochem Soc Trans. 1991 Aug;19(3):726–729. doi: 10.1042/bst0190726. [DOI] [PubMed] [Google Scholar]
  11. Joplin R., Lindsay J. G., Hubscher S. G., Johnson G. D., Shaw J. C., Strain A. J., Neuberger J. M. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology. 1991 Sep;14(3):442–447. [PubMed] [Google Scholar]
  12. Joplin R., Lindsay J. G., Johnson G. D., Strain A., Neuberger J. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet. 1992 Jan 11;339(8785):93–94. doi: 10.1016/0140-6736(92)91001-o. [DOI] [PubMed] [Google Scholar]
  13. Lin R. H., Mamula M. J., Hardin J. A., Janeway C. A., Jr Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med. 1991 Jun 1;173(6):1433–1439. doi: 10.1084/jem.173.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mutimer D. J., Fussey S. P., Yeaman S. J., Kelly P. J., James O. F., Bassendine M. F. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology. 1989 Oct;10(4):403–407. doi: 10.1002/hep.1840100402. [DOI] [PubMed] [Google Scholar]
  15. Surh C. D., Ahmed-Ansari A., Gershwin M. E. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis. J Immunol. 1990 Apr 1;144(7):2647–2652. [PubMed] [Google Scholar]
  16. Surh C. D., Roche T. E., Danner D. J., Ansari A., Coppel R. L., Prindiville T., Dickson E. R., Gershwin M. E. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology. 1989 Aug;10(2):127–133. doi: 10.1002/hep.1840100202. [DOI] [PubMed] [Google Scholar]
  17. Van de Water J., Ansari A. A., Surh C. D., Coppel R., Roche T., Bonkovsky H., Kaplan M., Gershwin M. E. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol. 1991 Jan 1;146(1):89–94. [PubMed] [Google Scholar]
  18. Van de Water J., Cooper A., Surh C. D., Coppel R., Danner D., Ansari A., Dickson R., Gershwin M. E. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989 May 25;320(21):1377–1380. doi: 10.1056/NEJM198905253202104. [DOI] [PubMed] [Google Scholar]
  19. Van de Water J., Gershwin M. E., Leung P., Ansari A., Coppel R. L. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med. 1988 Jun 1;167(6):1791–1799. doi: 10.1084/jem.167.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van de Water J., Surh C. D., Leung P. S., Krams S. M., Fregeau D., Davis P., Coppel R., Mackay I. R., Gershwin M. E. Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis. Semin Liver Dis. 1989 May;9(2):132–137. doi: 10.1055/s-2008-1040504. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES